Mechanisms and medical management of exercise intolerance in hypertrophic cardiomyopathy.

CURRENT PHARMACEUTICAL DESIGN(2015)

引用 30|浏览2
暂无评分
摘要
Hypertrophic cardiomyopathy (HCM) is an inherited disorder of cardiac sarcomeric proteins characterised by the presence of myocardial hypertrophy in the absence of abnormal loading conditions. Individuals with HCM can remain asymptomatic throughout their lives but many experience chest pain, symptoms of heart failure, syncope and sudden ventricular arrhythmias. Cardiopulmonary exercise testing is an important part of the assessment of patients with HCM who often have reduced peak oxygen consumption and a lower anaerobic threshold compared with healthy age-matched controls. This review will focus on mechanisms of exercise limitation, which are complex and multifactorial, and the options for medical management.
更多
查看译文
关键词
Hypertrophic cardiomyopathy,exercise capacity,heart failure,left ventricular tract obstruction,ischaemia,metabolism
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要